Neural tube defects are among the most challenging congenital conditions in medicine, with a devastating burden on patients, families,...

Artificial intelligence is no longer a peripheral tool in personalized medicine. AI is becoming a central driver of how diagnostics,...

On February 23, 2026, the U.S. Food and Drug Administration (FDA) released its Draft Guidance for Industry, “Considerations for the Use...

A recent Science Immunology paper reports a humanized Fc receptor mouse model designed to reflect human immune biology relevant to...

The health care and life sciences sector is entering a period of accelerated transformation shaped by new technologies, shifting...

This article was originally published in the AIPLA Chemical Practice Chronicles Fall 2025 newsletter and is republished here with...

The Long Life Family Study (LLFS) is a multi-decade, multicenter research program designed to uncover the genetic and biological factors...

For a decade, innovators at the intersection of artificial intelligence (AI) and precision medicine have faced a stubborn paradox: the...

The National Institutes of Health (NIH) recently announced the launch of a major artificial intelligence (AI) initiative aimed at...

In Google v. Sonos, the Federal Circuit soundly disposed of arguments that the patent-in-suit was unenforceable due to laches based on an...

Drug development can be slow, costly, and risky, often taking more than a decade and billions of dollars to bring a single therapy to the...

In a recent webinar hosted by the Licensing Executives Society, U.S. Patent and Trademark Office acting Director Coke Morgan Stewart...

The Trump administration is reportedly considering a proposal to charge patent holders a fee based on the value of their patents,...

The biotechnology and life science sectors underpin breakthroughs in health care, agriculture, and environmental sustainability by...

Personalized medicine—tailoring treatments to individual patients based on their genetic makeup, lifestyle, and environment—is...

Immunotherapies have provided successful precision therapy for human diseases by reducing side effects caused by untargeted...